Providers need to reconcile the tension between nutrition and traditional medicine for patients who view them as competing forces.
Maven Clinic’s agentic AI service meets rising demand by women for more personalized tools and raises the bar for brands in AI-assisted healthcare.
PowerMac and low-sugar Capri Sun aim to refresh iconic brands as better-for-you rivals crowd shelves.
A Massachusetts judge halts recent vaccine recommendation changes, boosting medical professionals' sway with parents and patients—for now.
But most are concerned about AI-related skill loss. Healthcare leaders need guardrails and training so doctors use AI daily without eroding their core skills.
Their ad budgets are shifting from linear TV to digital channels like CTV and social media, but big TV events still garner significant spending.
Structure Therapeutics' pill matches Novo’s and Lilly’s on weight loss, teeing up fiercer competition.
Most consumers give health apps a try, but just 3% stay after 30 days. AI features may be the fix, but only if brands don't overhype their value.
Amazon leans into the grocer’s premium brand power.
AI prep is changing visits, with doctors wary of misinformation but optimistic about patient education.
Americans across income brackets are cutting spending, rationing meds, and delaying surgery to pay for healthcare costs.
Tighter Medicare Advantage oversight may force insurers to cut perks, exit markets, and leave seniors navigating pricier plans.
The AI portal ties health records and wearables together as daily health conversations top 50 million.
Lilly’s new safety allegations add fuel to lawsuits and FDA actions targeting telehealth sellers of compounded weight loss drugs.
200,000 devices are erased, halting workflows and casting doubt on system security.
Novo drops court fights to secure GLP-1 distribution, which will drive other telehealth brands to weigh pharma deals against legal risk.
Standalone telemental health solutions could benefit from health systems' pursuit of online players that drive referrals.
After White House autism claims, acetaminophen use fell 10% before rebounding, showing how fast trust can waver.
Its $100 million acquisition brings compliant conversations to life sciences CRM amid rising AI adoption.
Parents aren’t as informed on the latest vaccine recommendations, stretching appointments with risk and safety talks.